PMID: 8625185Sep 1, 1995Paper

Phase I/II study of neoadjuvant intraarterial chemotherapy with mitomycin-C, vincristine, and cisplatin in patients with stage IIb bulky cervical carcinoma

S Y ParkK H Kim


Stage IIb bulky cervical carcinomas have been considered difficult to treat successfully by radiation and/or surgery, compared with smaller lesions. This study was designed to evaluate the efficacy of neoadjuvant pelvic intraarterial chemotherapy (IAC) and to determine the optimal dosage of cisplatin for reducing tumor volume in these patients. Twenty-one previously untreated patients with primary cervical carcinoma of more than 4 cm in greatest dimension and parametrial invasion were included in this study. Pelvic IAC was administered using a combination of mitomycin-C, 10 mg/m2; vincristine, 1 mg/m2; and cisplatin, 50 mg/m2 (MVC; group 1, 8 patients) or 75 mg/m2 (group 2, 13 patients). Tumor volumes were measured three-dimensionally by magnetic resonance imaging (MRI) before and after three courses of IAC. Clinical responses were evaluated with gynecologic examination and MRI; pathologic responses were evaluated with histologic examinations of surgical specimens. The mean volume reduction rate (74.2% vs. 97.2% in groups 1 and 2, respectively, P = 0.0022), the clinical complete response rate (0% vs. 69.2%, P = 0.0033), and the pathologic complete response rate (0% vs. 46.2%, P = 0.0445) were significantly higher in group 2. Ty...Continue Reading


Mar 1, 1979·International Journal of Radiation Oncology, Biology, Physics·M M HreshchyshynJ A Blessing
Jan 1, 1992·International Journal of Radiation Oncology, Biology, Physics·P WorkmanK L Kooistra
Jun 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·L SouhamiT R Silveira
Feb 1, 1991·Geburtshilfe und Frauenheilkunde·P G KnapsteinC Düber
Jul 1, 1989·Cardiovascular and Interventional Radiology·Y YamashitaH Okamura
Jul 1, 1989·Clinical Radiology·A GrecoM C Anderson
Apr 1, 1989·Radiology·K TogashiI Konishi
Dec 1, 1983·American Journal of Obstetrics and Gynecology·M S PiverL Blumenson
May 1, 1984·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J M Collins
Mar 1, 1983·International Journal of Radiation Oncology, Biology, Physics·A MartinezJ Portnuff
Dec 1, 1981·International Journal of Radiation Oncology, Biology, Physics·P Anderson, S Dische
Nov 1, 1980·American Journal of Obstetrics and Gynecology·C K ChungR Mortel
Sep 1, 1992·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·M.H.N. TattersallM. Coppleson

❮ Previous
Next ❯


May 11, 1999·Drug Discovery Today·J Saunders, C M Tarby
Aug 30, 2008·Surgical Oncology Clinics of North America·Takeshi MaruoYonson Ku
Jun 13, 2006·The Journal of Obstetrics and Gynaecology Research·Hong-Bing CaiHou-Han Yin
Jan 1, 1997·Clinical Oncology : a Journal of the Royal College of Radiologists·N Jackson, N B Hassan
Mar 10, 2001·Cancer Treatment Reviews·W T Bradner
Jul 1, 2010·Experimental and Therapeutic Medicine·Shoji KakuTakashi Murakami

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.